BioCryst stock rises after $264 million sale of European ORLADEYO business – RP Digital

Business

BioCryst stock rises after $264 million sale of European ORLADEYO business

June 27, 20251 min0

BioCryst stock rises after $264 million sale of European ORLADEYO business

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250